LEADER 04134nam  22007455  450 
001 9910254258403321
005 20200703012625.0
010   $a981-10-0063-8
024 7 $a10.1007/978-981-10-0063-8
035   $a(CKB)3710000000579357
035   $a(EBL)4333617
035   $a(SSID)ssj0001606881
035   $a(PQKBManifestationID)16316863
035   $a(PQKBTitleCode)TC0001606881
035   $a(PQKBWorkID)14896709
035   $a(PQKB)11254790
035   $a(DE-He213)978-981-10-0063-8
035   $a(MiAaPQ)EBC4333617
035   $a(PPN)191701432
035   $a(EXLCZ)993710000000579357
100   $a20160111d2016      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aAdvances in Nanotheranostics II $eCancer Theranostic Nanomedicine /$fedited by Zhifei Dai
205   $a1st ed. 2016.
210  1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2016.
215   $a1 online resource (385 p.)
225 1 $aSpringer Series in Biomaterials Science and Engineering,$x2195-0644 ;$v7
300   $aDescription based upon print version of record.
311   $a981-10-0061-1 
320   $aIncludes bibliographical references at the end of each chapters.
330   $aThis book surveys recent advances in theranostics based on magnetic nanoparticles, ultrasound contrast agents, silica nanoparticles and polymeric micelles. It presents magnetic nanoparticles, which offer a robust tool for contrast enhanced MRI imaging, magnetic targeting, controlled drug delivery, molecular imaging guided gene therapy, magnetic hyperthermia, and controlling cell fate. Multifunctional ultrasound contrast agents have great potential in ultrasound molecular imaging, multimodal imaging, drug/gene delivery, and integrated diagnostics and therapeutics. Due to their diversity and multifunctionality, polymeric micelles and silica-based nanocomposites are highly capable of enhancing the efficacy of multimodal imaging and synergistic cancer therapy. This comprehensive book summarizes the main advances in multifunctional nanoprobes for targeted imaging and therapy of gastric cancer, and explores the clinical translational prospects and challenges. Although more research is needed to overcome the substantial obstacles that impede the development and availability of nanotheranostic products, such nontrivial nanoagents are expected to revolutionize medical treatments and help to realize the potential of personalized medicine to diagnose, treat, and follow-up patients with cancer. Zhifei Dai is a Professor at the Department of Biomedical Engineering, College of Engineering, Peking University, China.
410  0$aSpringer Series in Biomaterials Science and Engineering,$x2195-0644 ;$v7
606   $aBiomedical engineering
606   $aNanotechnology
606   $aRadiology
606   $aBiomaterials
606   $aOncology  
606   $aBiomedical Engineering and Bioengineering$3https://scigraph.springernature.com/ontologies/product-market-codes/T2700X
606   $aNanotechnology$3https://scigraph.springernature.com/ontologies/product-market-codes/Z14000
606   $aImaging / Radiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H29005
606   $aBiomaterials$3https://scigraph.springernature.com/ontologies/product-market-codes/Z13000
606   $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160
615  0$aBiomedical engineering.
615  0$aNanotechnology.
615  0$aRadiology.
615  0$aBiomaterials.
615  0$aOncology  .
615 14$aBiomedical Engineering and Bioengineering.
615 24$aNanotechnology.
615 24$aImaging / Radiology.
615 24$aBiomaterials.
615 24$aOncology.
676   $a610.284
702   $aDai$b Zhifei$4edt$4http://id.loc.gov/vocabulary/relators/edt
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910254258403321
996   $aAdvances in Nanotheranostics II$91540614
997   $aUNINA